Better Therapeutics, Inc. (BTTX) Net Cash Provided by (Used in) Operating Activities USD 2020 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Better Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2020 to 2023.
  • Better Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$13.8 M, a 55.8% decline year-over-year.
  • Better Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$28.9 M, a 6.13% increase from 2021.
  • Better Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$30.8 M, a 434% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly Data (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$13.8 M -$4.95 M -55.8% Jan 1, 2023 Mar 31, 2023 10-Q 2023-08-09
Q1 2022 -$8.86 M -$6.24 M -238% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 -$2.62 M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q3 2020 -$1 K* Jul 31, 2020 Sep 30, 2020 10-Q 2021-11-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.